Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

Guila Dayan; Mathieu Lupien; Anick Auger; Silvia I. Anghel; Walter Rocha; Sébastien Croisetière; John A. Katzenellenbogen; Sylvie Mader

doi:10.1124/mol.105.021931

Research ArticleArticle

Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

Guila Dayan, Mathieu Lupien, Anick Auger, Silvia I. Anghel, Walter Rocha, Sébastien Croisetière, John A. Katzenellenbogen and Sylvie Mader

Molecular Pharmacology August 2006, 70 (2) 579-588; DOI: https://doi.org/10.1124/mol.105.021931

Guila Dayan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mathieu Lupien

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anick Auger

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Silvia I. Anghel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Walter Rocha

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sébastien Croisetière

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John A. Katzenellenbogen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sylvie Mader

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Molecular Pharmacology

Vol. 70, Issue 2

1 Aug 2006

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleArticle

Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

Guila Dayan, Mathieu Lupien, Anick Auger, Silvia I. Anghel, Walter Rocha, Sébastien Croisetière, John A. Katzenellenbogen and Sylvie Mader

Molecular Pharmacology August 1, 2006, 70 (2) 579-588; DOI: https://doi.org/10.1124/mol.105.021931

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleArticle

Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

Guila Dayan, Mathieu Lupien, Anick Auger, Silvia I. Anghel, Walter Rocha, Sébastien Croisetière, John A. Katzenellenbogen and Sylvie Mader

Molecular Pharmacology August 1, 2006, 70 (2) 579-588; DOI: https://doi.org/10.1124/mol.105.021931

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

Plain text

Vertical Tabs

Jump to comment:

In this issue

Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals